Key clinical trials of bimatoprost implant (Allergan)
| Identifier | Indication | Phase | Drugs/procedures | Location(s) | Status |
|---|---|---|---|---|---|
|
ARTEMIS-1; |
OAG or OHT | III | Bimatoprost implant; sham implant; timolol; timolol vehicle (placebo) | Multinational | Completed |
|
ARTEMIS-2; |
OAG or OHT | III | Bimatoprost implant; sham implant; timolol; timolol vehicle (placebo) | Multinational | Ongoing |
| NCT02636946 | OAG or OHT | III | Bimatoprost implant; sham implant; SLT; sham SLT | Multinational | Ongoing |
| NCT02507687 | OAG or OHT | III | Bimatoprost implant; sham implant; SLT; sham SLT | Multinational | Ongoing |
| NCT03850782 | OAG or OHT | III | Bimatoprost implant | Multinational | Recruiting |
| NCT03891446 | OAG or OHT | III | Bimatoprost implant | Multinational | Recruiting |
| NCT04285580 | OAG or OHT | III | Bimatoprost implant; bimatoprost ophthalmic solution | USA | Planned |
| APOLLO; NCT01157364 | OAG | I/II | Bimatoprost implant; bimatoprost ophthalmic solution | Multinational | Completed |
OAG open-angle glaucoma, OHT ocular hypertension, SLT selective laser trabeculoplasty